T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Prosperity Bancshares
PB
$8.97B
| $169M | 0.02% |
2,254,178
-67,216
| -3% | -$4.91M |
|
602
Bausch Health
BHC
$2.37B
| $168M | 0.02% |
5,297,276
-572,585
| -10% | -$16.8M |
|
603
Simon Property Group
SPG
$71.7B
| $168M | 0.02% |
1,474,751
+4,721
| +0.3% | +$492K |
|
604
Cactus
WHD
$5.78B
| $167M | 0.02% |
5,442,846
+131,176
| +2% | +$3.97M |
|
605
Illumina
ILMN
$29.1B
| $167M | 0.02% |
445,947
+155,950
| +54% | +$63.6M |
|
|
EQC
606
DELISTED
Equity Commonwealth
EQC
| $166M | 0.02% |
5,969,829
+57,847
| +1% | +$1.63M |
|
|
RDUS
607
DELISTED
Radius Health, Inc.
RDUS
| $166M | 0.02% |
7,954,285
+1,604,837
| +25% | +$33.8M |
|
608
National Fuel Gas
NFG
$7.75B
| $165M | 0.02% |
3,300,289
-526,566
| -14% | -$23.9M |
|
609
Scholastic
SCHL
$784M
| $165M | 0.02% |
5,476,939
+793,738
| +17% | +$22.3M |
|
610
Alignment Healthcare
ALHC
$2.79B
| $165M | 0.02% |
+7,829,547
| New | +$153M |
|
611
SelectQuote
SLQT
$126M
| $164M | 0.02% |
5,554,177
+20,257
| +0.4% | +$531K |
|
612
LCI Industries
LCII
$2.6B
| $164M | 0.02% |
1,238,471
-47,245
| -4% | -$6.6M |
|
613
McKesson
MCK
$99.9B
| $164M | 0.02% |
839,892
-40,333
| -5% | -$7.36M |
|
614
Iovance Biotherapeutics
IOVA
$2.95B
| $163M | 0.02% |
5,135,456
-2,246,749
| -30% | -$93.1M |
|
615
NovoCure
NVCR
$2.02B
| $162M | 0.02% |
1,227,702
-10,502
| -0.8% | -$1.66M |
|
616
Target
TGT
$70.6B
| $162M | 0.02% |
819,042
-60,885
| -7% | -$11.4M |
|
617
StepStone Group
STEP
$4.28B
| $162M | 0.02% |
4,583,946
+265,049
| +6% | +$9.33M |
|
618
BP
BP
$110B
| $162M | 0.02% |
6,633,429
-645,781
| -9% | -$15.6M |
|
619
Sunstone Hotel Investors
SHO
$2.02B
| $161M | 0.02% |
12,915,610
+900,302
| +7% | +$10.8M |
|
620
Liberty Energy
LBRT
$3.45B
| $161M | 0.02% |
14,233,198
-550,560
| -4% | -$6.62M |
|
|
ETRN
621
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $160M | 0.02% |
19,650,107
+3,868,996
| +25% | +$29.4M |
|
|
AEPPL
622
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
| $160M | 0.02% |
3,205,223
-1,109,065
| -26% | -$52.8M |
|
623
Rocket Pharmaceuticals
RCKT
$367M
| $160M | 0.02% |
3,598,835
+119,514
| +3% | +$6.56M |
|
624
Waste Management
WM
$89.6B
| $160M | 0.02% |
1,237,400
+564,338
| +84% | +$66M |
|
625
McCormick & Company Non-Voting
MKC
$14.6B
| $160M | 0.02% |
1,789,845
-27,206
| -1% | -$2.42M |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.